LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management
Go back to LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management| (NASDAQ: LFMD) | Delayed: 4.31 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.31 | 52 Week High | $ | |||
| Open | $4.31 | 52 Week Low | $ | |||
| Day High | $4.31 | P/E | N/A | |||
| Day Low | $4.31 | EPS | $ | |||
| Volume | 1,592 | |||||
| (NASDAQ: LFMDP) | Delayed: 23.46 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.46 | 52 Week High | $ | |||
| Open | $23.46 | 52 Week Low | $ | |||
| Day High | $23.46 | P/E | N/A | |||
| Day Low | $23.46 | EPS | $ | |||
| Volume | 147 | |||||
